Grupo MICOBAC-UN, Departamento de Microbiología, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, Colombia.
Experimental Pathology Section, Department of Pathology, National Institute of Medical Sciences and Nutrition, México D.F., Mexico.
Pathog Glob Health. 2019 Dec;113(8):336-351. doi: 10.1080/20477724.2019.1710066. Epub 2020 Jan 5.
Lineage 2 (East Asian), which includes the Beijing genotype, is one of the most prevalent lineages of (Mtb) throughout the world. The Beijing family is associated to hypervirulence and drug-resistant tuberculosis. The study of this genotype's circulation in Latin America is crucial for achieving total control of TB, the goal established by the World Health Organization, for the American sub-continent, before 2035. In this sense, the present work presents an overview of the status of the Beijing genotype for this region, with a bibliographical review, and data analysis of MIRU-VNTRs for available Beijing isolates. Certain countries present a prevalent trend of <5%, suggesting low transmissibility for the region, with the exception of Cuba (17.2%), Perú (16%) and Colombia (5%). Minimum Spanning Tree analysis, obtained from MIRU-VNTR data, shows distribution of specific clonal complex strains in each country. From this data, in most countries, we found that molecular epidemiology has not been a tool used for the control of TB, suggesting that the Beijing genotype may be underestimated in Latin America. It is recommended that countries with the highest incidence of the Beijing genotype use effective control strategies and increased care, as a requirement for public health systems.
(结核分枝杆菌)的主要流行株之一包括东亚谱系(Lineage 2,包括北京基因型)。北京家族与高毒力和耐药结核病有关。研究这种基因型在拉丁美洲的传播情况对于实现世界卫生组织为拉丁美洲次大陆设定的 2035 年全面控制结核病的目标至关重要。在这方面,本工作通过文献综述和对现有北京分离株的 MIRU-VNTR 数据分析,概述了该地区北京基因型的现状。某些国家的流行趋势<5%,表明该地区的传染性较低,但古巴(17.2%)、秘鲁(16%)和哥伦比亚(5%)除外。从 MIRU-VNTR 数据获得的最小生成树分析显示了每个国家特定克隆复合体菌株的分布。根据这些数据,在大多数国家,我们发现分子流行病学尚未成为结核病控制的工具,这表明北京基因型在拉丁美洲可能被低估了。建议北京基因型发病率最高的国家使用有效的控制策略和加强护理,作为公共卫生系统的要求。